Role of C-Reactive Protein in Determining Microvascular Function in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

被引:3
|
作者
Sezer, Murat [1 ]
Akdeniz, Cansu [1 ]
Aslanger, Emre [1 ]
Kaplan, Abdullah [1 ]
Yilmaz, Akar [1 ]
Guz, Goksel [1 ]
Umman, Berrin [1 ]
Bugra, Zehra [1 ]
Umman, Sabahattin [1 ]
机构
[1] Istanbul Univ, Istanbul Fac Med, Dept Cardiol, Istanbul, Turkey
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2013年 / 111卷 / 12期
关键词
PROGNOSTIC VALUE; UNSTABLE ANGINA; INFLAMMATION; VASOREACTIVITY; RISK; COLOCALIZES; DYSFUNCTION; COMPLEMENT; ACTIVATION; DILATION;
D O I
10.1016/j.amjcard.2013.02.029
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The extent of coronary microvascular dysfunction might be related, not only to patient characteristics and procedural factors, but also to the inflammatory status. The aim of the present study was to examine a possible association between inflammation, as reflected by the serum C-reactive protein (CRP) levels, and the extent of baseline and post-percutaneous coronary intervention (PCI) coronary microvascular dysfunction in patients with non-ST-segment elevation acute coronary syndrome undergoing PCI. A total of 42 patients undergoing PCI for non-ST-segment elevation acute coronary syndrome were enrolled. Coronary microvascular resistance (MR) was determined in the territory of culprit artery using a Doppler probe- and a pressure sensor-equipped guidewire both before (taking the collateral blood into account) and after PCI. The periprocedural changes in MR were calculated. The CRP levels at admission were correlated with the pre-PCI MR (r = 0.498, p = 0.001), post-PCI MR (r = 0.429, p = 0.005), and periprocedural changes in MR (r = 0.785, p <0.001). On multivariate regression analysis, the only predictor of the pre-PCI (beta = 0.531, p = 0.002) and post-PCI (beta = 0.471, p = 0.012) MR was the serum CRP concentration. Likewise, the periprocedural changes in MR was predicted by the serum CRP levels (beta = 0.677, p = 0.001) and the presence of angiographic thrombus (beta = -0.275, p = 0.02). In conclusion, these results have shown that the CRP level is related to increased coronary MR in the territory of the culprit lesion. This suggests that inflammatory processes might play a role in microvascular impairment in patients with non-ST-segment elevation acute coronary syndrome. (c) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:1734 / 1738
页数:5
相关论文
共 50 条
  • [1] Determinants of C-reactive protein increase in non-ST-segment elevation acute coronary syndrome
    Sanchis, J
    Bodí, V
    Lláer, A
    Facila, L
    Martínez-Brotons, A
    Insa, L
    Chorro, FJ
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 : 305 - 306
  • [2] Percutaneous coronary intervention in diabetic patients with non-ST-segment elevation acute coronary syndromes
    Roffi, M
    Topol, EJ
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 (03) : 190 - 198
  • [3] Prognostic implication of serum glycated albumin for patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention
    Liu, Chi
    Zhao, Qi
    Ma, Xiaoteng
    Cheng, Yujing
    Sun, Yan
    Zhang, Dai
    Liu, Xiaoli
    Zhou, Yujie
    [J]. CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [4] Prognostic implication of serum glycated albumin for patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention
    Chi Liu
    Qi Zhao
    Xiaoteng Ma
    Yujing Cheng
    Yan Sun
    Dai Zhang
    Xiaoli Liu
    Yujie Zhou
    [J]. Cardiovascular Diabetology, 21
  • [5] C-Reactive Protein Elevation and Rapid Angiographic Progression of Nonculprit Lesion in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome
    Nakachi, Tatsuya
    Kosuge, Masami
    Hibi, Kiyoshi
    Ebina, Toshiaki
    Hashiba, Katsutaka
    Mitsuhashi, Takayuki
    Endo, Mitsuaki
    Umemura, Satoshi
    Kimura, Kazuo
    [J]. CIRCULATION JOURNAL, 2008, 72 (12) : 1953 - 1959
  • [6] Percutaneous coronary intervention in treatment of multivessel coronary artery disease in patients with non-ST-segment elevation acute coronary syndrome
    Gasior, Pawel
    Desperak, Piotr
    Gierlaszynska, Karolina
    Hawranek, Michal
    Gierlotka, Marek
    Gasior, Mariusz
    Polonski, Lech
    [J]. POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2013, 9 (02): : 136 - 145
  • [7] Usefulness and Safety of Vorapaxar in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention (from the TRACER Trial)
    Valgimigli, Marco
    Tricoci, Pierluigi
    Huang, Zhen
    Aylward, Philip E.
    Armstrong, Paul W.
    Van de Werf, Frans
    Leonardi, Sergio
    White, Harvey D.
    Widimsky, Petr
    Harrington, Robert A.
    Cequier, Angel
    Chen, Edmond
    Lokhnygina, Yuliya
    Wallentin, Lars
    Strony, John
    Mahaffey, Kenneth W.
    Moliterno, David J.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2014, 114 (05): : 665 - 673
  • [8] Association of Parenteral Anticoagulation Therapy With Outcomes in Chinese Patients Undergoing Percutaneous Coronary Intervention for Non-ST-Segment Elevation Acute Coronary Syndrome
    Chen, Ji-Yan
    He, Peng-Cheng
    Liu, Yuan-Hui
    Wei, Xue-Biao
    Jiang, Lei
    Guo, Wei
    Duan, Chong-Yang
    Guo, Yan-Song
    Yu, Xiao-Ping
    Li, Jun
    Li, Wen-Sheng
    Zhou, Ying-Ling
    Lin, Chun-Ying
    Luo, Jian-Fang
    Yu, Dan-Qing
    Chen, Zhu-Jun
    Chen, Wei
    Chen, Yi-Yue
    Guo, Zhi-Qiang
    Geng, Qing-Shan
    Tan, Ning
    [J]. JAMA INTERNAL MEDICINE, 2019, 179 (02) : 186 - 194
  • [9] Value of serial measurements of C-reactive protein in non-ST-segment elevation acute coronary syndromes
    Kosuge, Masami
    Kimura, Kazuo
    Ebina, Toshiaki
    Hibi, Kiyoshi
    Tukahara, Kengo
    Okuda, Jyun
    Uchino, Kazuaki
    Umemura, Satoshi
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 186A - 186A
  • [10] Impact of persistent subclinical hypothyroidism on clinical outcomes in non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention
    Han, Chuyi
    Xu, Kaihang
    Wang, Le
    Zhang, Yingyi
    Zhang, Rui
    Wei, Ao
    Dong, Lijie
    Hu, Yuecheng
    Xu, Jinghan
    Li, Wenyu
    Li, Tingting
    Liu, Chunwei
    Qi, Wei
    Jin, Dongxia
    Zhang, Jingxia
    Cong, Hongliang
    [J]. CLINICAL ENDOCRINOLOGY, 2022, 96 (01) : 70 - 81